These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1271719)

  • 1. [Evaluation of antipeptic effect of medicinal preparations in treatment of ulcer disease].
    Masevich TsG; Gorshkov VA
    Klin Med (Mosk); 1976 Feb; 54(2):51-4. PubMed ID: 1271719
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of peptic ulcer with the use of cholinolytic preparations with various modes of action].
    Fishzon-Ryss IuI
    Sov Med; 1965 Oct; 28(10):67-74. PubMed ID: 4380937
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of ulcerous disease with a preparation of colloidal bismuth].
    Marano R; Nacchiero M; Martino Bonomo G
    Clin Ter; 1974 Apr; 69(2):113-31. PubMed ID: 4599446
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vitamin B1, B6, PP and C balance in patients with ulcer disease under conditions of complex treatment].
    Litinskaia EV
    Vrach Delo; 1974 Dec; (12):71-5. PubMed ID: 4280658
    [No Abstract]   [Full Text] [Related]  

  • 6. Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach.
    Fedotin MS
    Postgrad Med; 1993 Sep; 94(3):38-40, 43-5. PubMed ID: 8361941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori eradication with bismuth subnitrate, oxytetracycline and metronidazole in patients with peptic ulcer disease.
    Wilhelmsen I; Weberg R; Berstad K; Hausken T; Hundal O; Berstad A
    Hepatogastroenterology; 1994 Feb; 41(1):43-7. PubMed ID: 8175114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori.
    Hunt RH
    Am J Gastroenterol; 1997 Apr; 92(4 Suppl):36S-40S; discussion 40S-43S. PubMed ID: 9127625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience with the clinical use of a complex of amino acids and anabolic preparations in treating peptic ulcer patients].
    Trusov VV; Vakhrushev IaM
    Ter Arkh; 1984; 56(2):52-5. PubMed ID: 6710406
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic approaches to recurrent peptic ulcer disease.
    Cave DR
    Hosp Pract (Off Ed); 1992 Sep; 27(9A):33-40, 43, 47-9. PubMed ID: 1522168
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of dimedrol in the combined treatment of peptic ulcer patients].
    Kushnir VE; Reĭngardt BK; Spivak AM
    Vrach Delo; 1983 Apr; (4):40-2. PubMed ID: 6868531
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of neurotropic drugs on the course of peptic ulcer].
    Oparin AG; Fedchenko IuG
    Klin Med (Mosk); 1987 Oct; 65(10):59-61. PubMed ID: 3431058
    [No Abstract]   [Full Text] [Related]  

  • 13. Peptic ulcer treatment today--is there a role for maintenance therapy?
    Breslin NP; O'Morain C
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):116-21. PubMed ID: 9646190
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of gastroduodenal ulcer with plasmutan].
    Berard E; Gallavardin M
    Med Chir Dig; 1975; 4(1):57-60. PubMed ID: 1160427
    [No Abstract]   [Full Text] [Related]  

  • 15. [Reparative agents in the treatment of patients with peptic ulcer].
    Kreĭdich AM; Perepel'chenko AI; Tsymbaliuk VT; Ostapenko GI; Pan'ko LM
    Vrach Delo; 1988 Aug; (8):7-9. PubMed ID: 3206889
    [No Abstract]   [Full Text] [Related]  

  • 16. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
    Karita M; Tsuda M; Okita K; Sugiyama T; Nakazawa T
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S31-4. PubMed ID: 8574732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peptic ulcer treatment effectiveness in pulmonary tuberculosis patients].
    Petrenko VM; Zinevich AK
    Vrach Delo; 1980 Sep; (9):40-3. PubMed ID: 7423947
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative evaluation of the therapeutic effect of oxyferriscorbone in peptic ulcer].
    Spivak AM; Reĭngardt VK; Galetskaia TM; Liashko NA; Litinskaia EV
    Vrach Delo; 1985 Aug; (8):56-9. PubMed ID: 4072113
    [No Abstract]   [Full Text] [Related]  

  • 20. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
    Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.